These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 10329070)

  • 1. Benestent II, a remake of benestent I? Or a step towards the era of stentoplasty?
    Serruys PW; Kay IP
    Eur Heart J; 1999 Jun; 20(11):779-81. PubMed ID: 10329070
    [No Abstract]   [Full Text] [Related]  

  • 2. [PTCA or alternative techniques? Balloon angioplasty remains dominant].
    Reifart N
    Z Kardiol; 1995; 84 Suppl 2():43-52. PubMed ID: 7571782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benestent II: back to the future.
    Emanuelsson H; van der Giessen WJ; Serruys PW
    J Interv Cardiol; 1994 Dec; 7(6):587-92. PubMed ID: 10155208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in restenosis propensity of devices for transluminal coronary intervention. A quantitative angiographic comparison of balloon angioplasty, directional atherectomy, stent implantation and excimer laser angioplasty. CARPORT, MERCATOR, MARCATOR, PARK, and BENESTENT Trial Groups.
    Foley DP; Melkert R; Umans VA; de Jaegere PP; Strikwerda S; de Feyter PJ; Serruys PW
    Eur Heart J; 1995 Oct; 16(10):1331-46. PubMed ID: 8746901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Provisional stenting--stent-like balloon angioplasty: evidence to define the continuing role of balloon angioplasty for percutaneous coronary revascularization.
    Foley DP; Serruys PW
    Semin Interv Cardiol; 1996 Dec; 1(4):269-73. PubMed ID: 9552521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is provisional stenting the effective option? The WIDEST study (Wiktor stent in de novo stenosis). Widest Trial Investigators' Group.
    Fluck DS; Chenu P; Mills P; Davies A; Street J; Paul E; Balcon R; Layton CA
    Heart; 2000 Nov; 84(5):522-8. PubMed ID: 11040014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The challenge of high-risk patients: diabetes and small vessels.
    Kereiakes D
    J Invasive Cardiol; 2004 Sep; 16 Suppl F():3F-7F; discussion 18F-21F. PubMed ID: 23573646
    [No Abstract]   [Full Text] [Related]  

  • 8. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group.
    Serruys PW; de Jaegere P; Kiemeneij F; Macaya C; Rutsch W; Heyndrickx G; Emanuelsson H; Marco J; Legrand V; Materne P
    N Engl J Med; 1994 Aug; 331(8):489-95. PubMed ID: 8041413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of coronary artery stents on mortality and nonfatal myocardial infarction: meta-analysis of randomized trials comparing a strategy of routine stenting with that of balloon angioplasty.
    Al Suwaidi J; Holmes DR; Salam AM; Lennon R; Berger PB
    Am Heart J; 2004 May; 147(5):815-22. PubMed ID: 15131536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pushing the limits: is there an optimal therapy for very small vessels?
    Roguin A; Grenadier E
    J Invasive Cardiol; 2005 Aug; 17(8):413-4. PubMed ID: 16079446
    [No Abstract]   [Full Text] [Related]  

  • 11. Balloon alignment T-stenting for bifurcation coronary artery disease using the sirolimus-eluting stent.
    Rizik DG; Dowler DA; Villegas BJ
    J Invasive Cardiol; 2005 Aug; 17(8):437-9. PubMed ID: 16079451
    [No Abstract]   [Full Text] [Related]  

  • 12. Are drug-eluting stents cost-effective when compared with bare-metal stents in a real-world setting?
    Moussa I
    Nat Clin Pract Cardiovasc Med; 2006 Apr; 3(4):192-3. PubMed ID: 16568127
    [No Abstract]   [Full Text] [Related]  

  • 13. [Stents and de novo coronary lesions. Meta-analysis].
    Masotti M; Serra A; Betriu A
    Rev Esp Cardiol; 1997; 50 Suppl 2():3-9. PubMed ID: 9221454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and angiographic outcome of elective stent implantation in small coronary vessels: an analysis of the BENESTENT trial.
    Keane D; Azar AJ; de Jaegere P; Rutsch W; de Bruyne B; Legrand V; Kiemeneij F; de Feyter P; van de Heuvel P; Ozaki Y; Morel MA; Serruys PW
    Semin Interv Cardiol; 1996 Dec; 1(4):255-62. PubMed ID: 9552519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic navigation: a pivotal technology.
    Raizner AE
    Catheter Cardiovasc Interv; 2007 May; 69(6):856. PubMed ID: 17427904
    [No Abstract]   [Full Text] [Related]  

  • 16. Tackling complex cases in the drug-eluting stents era: where are we now?
    Holmes D
    J Invasive Cardiol; 2004 Sep; 16 Suppl F():8F-11F; discussion 18F-21F. PubMed ID: 23573647
    [No Abstract]   [Full Text] [Related]  

  • 17. Cost effectiveness of stent implantation versus PTCA: the BENESTENT experience.
    Van Hout BA; van der Woude T; de Jaegere PP; van den Brand M; van Es GA; Serruys PW; Morel MA
    Semin Interv Cardiol; 1996 Dec; 1(4):263-8. PubMed ID: 9552520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treating multivessel disease in the era of coated stents: introduction.
    Di Mario C; Mikhail G
    Heart; 2004 Sep; 90(9):989. PubMed ID: 15311439
    [No Abstract]   [Full Text] [Related]  

  • 19. Coronary stenting without predilatation: a clinical routine with Jomed Delivery System.
    Veselka J; Tesar D; Mates M
    Catheter Cardiovasc Interv; 1999 Jan; 46(1):121-2. PubMed ID: 10348586
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term outcome after coronary angioplasty: where do we stand?
    Papafaklis MI; Michalis LK
    Hellenic J Cardiol; 2005; 46(6):375-9. PubMed ID: 16422123
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.